Showing results (301-310 of 403) with videos related to
Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2012
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosisMarisa Benagiano, Fabio Munari, Alessandra Ciervo, et al.Experimental Hematology & Oncology|May 6, 2025
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneityTania Rossi, Sara Bandini, Michele Zanoni, et al.Critical Reviews in Oncology/Hematology|August 12, 2018
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaMatteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, et al.Diabetologia|February 10, 2026
Feasibility and performance of minimal-volume capillary blood screening for type 1 diabetes and coeliac disease autoantibodies across all age groups: the UNISCREEN population studyIlaria Marzinotto, Elena Bazzigaluppi, Cristina Brigatti, et al.Molecular Neurobiology|May 21, 2026
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network AnalysisMartina De Felice, Alessia Pascazio, Rebecca Piccarducci, et al.Frontiers in Public Health|February 26, 2025
Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN studySara Angiulli, Aurora Merolla, Elisa Borgonovo, et al.International Journal of Molecular Sciences|January 7, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?Paola Ulivi, Angelo Delmonte, Elisa Chiadini, et al.Journal of Clinical Medicine|April 11, 2020
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.Ebiomedicine|May 4, 2019
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from bloodMichela Notarangelo, Chiara Zucal, Angelika Modelska, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase InhibitorsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.Pageof 41